- Patent Title: Safe and effective beta-lactamase dosing for microbiome protection
-
Application No.: US16892647Application Date: 2020-06-04
-
Publication No.: US11253577B2Publication Date: 2022-02-22
- Inventor: Joseph Sliman
- Applicant: Synthetic Biologics, Inc.
- Applicant Address: US MD Rockville
- Assignee: Synthetic Biologics, Inc.
- Current Assignee: Synthetic Biologics, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: A61K38/50
- IPC: A61K38/50 ; A61K31/546 ; A61K45/06 ; A61K9/50
Abstract:
The present invention relates to, inter alia, safe and effective doses of a beta-lactamase for, e.g. microbiome protection.
Public/Granted literature
- US20200297824A1 SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION Public/Granted day:2020-09-24
Information query
IPC分类:
